SAN FRANCISCO, Aug. 9, 2021 /PRNewswire/ -- Invitae
Corporation (NYSE: NVTA), a leading medical genetics company, today
announced that members of its management team will participate in a
fireside chat at the UBS Genomics 2.0 and MedTech Innovations
Summit on Wednesday, August 11, 2021
at 11:00 a.m. PT and Sean George, chief executive officer of Invitae,
will participate in the NGS Technologies panel presentation at
1:00 p.m. PT, both at Montage Laguna
Beach.
The live webcasts of the fireside chat and the panel
presentation may be accessed by visiting the investors section of
the company website at ir.invitae.com. Replays of the webcasts will
be available shortly after the conclusion of the fireside chat and
panel presentation.
About Invitae
Invitae Corporation (NYSE: NVTA) is a leading medical
genetics company, whose mission is to bring comprehensive genetic
information into mainstream medicine to improve healthcare for
billions of people. Invitae's goal is to aggregate the world's
genetic tests into a single service with higher quality, faster
turnaround time, and lower prices. For more information, visit the
company's website at invitae.com.
Contact:
ir@invitae.com
(628) 213-3369
View original content to download
multimedia:https://www.prnewswire.com/news-releases/invitae-to-present-at-the-ubs-genomics-2-0-and-medtech-innovations-summit-301351402.html
SOURCE Invitae Corporation